Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Fungal Eye Infections Linked to Recalled Franck’s Pharmacy Drugs May 29, 2012 Staff Writers Add Your Comments Reports of eye infections have been linked to drugs distributed by Franck’s Pharmacy, resulting in a recall for all medications compounded by the pharmacy. A safety alert was posted on the FDA’s website on May 25, announcing the recall for all sterile human and veterinary prescriptions distributed by Franck’s Pharmacy, which is based in Ocala, Florida. This action came after FDA investigators found microorganisms and fungal growth in environmental samples from the pharmacy’s clean room, suggesting that the medications may pose a risk of infection. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Investigations have linked reports of fungal eye infections to both the pharmacy’s Brilliant Blue G eye surgery compound, which was recalled in March, as well as intravitreal injections of triamcinolone products given during eye surgery. According to a report issued earlier this month by the U.S. Centers for Disease Control and Prevention (CDC), there have been at least 33 confirmed or probable cases of fungal endophthalmitis in patients in seven states who underwent invasive eye surgery where Franck’s Pharmacy compounded drugs were used. Brilliant Blue G was linked to 20 of those cases, and triamcinolone products were linked to another 13. Franck’s Pharmacy compounded drugs were distributed nationwide, and infections linked to the pharmacy’s products have been confirmed as far away as California. Endophthalmitis is an eye infection that results in inflammation of the eye and can lead to vision loss and the loss of the entire eye in some cases. Antibiotics are usually applied via intravitreal injection (an injection into the eye itself), but in some cases eye removal is required. The FDA moved to recall all of the company’s drugs after finding multiple bacterial and fungal species infesting unopened bottles and intact syringes from the pharmacy. The FDA then found fungal growth and bacteria in the pharmacy’s clean room. The recall affects all sterile products distributed by Franck’s Pharmacy since November 21, 2011. The FDA is advising that no drugs be used from Franck’s Pharmacy that were made since November 2011. More Lawsuit Stories Amazon Nitrous Oxide Lawsuit Alleges Platform Responsible for Whippet Injuries January 29, 2026 Roblox Injury Lawyers Seek Leadership Roles in Child Exploitation MDL January 29, 2026 GLP-1 Diabetes Drugs Linked to Increased Risk of Kidney Side Effects January 29, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Amazon Nitrous Oxide Lawsuit Alleges Platform Responsible for Whippet Injuries (Posted: today) A Georgia man has filed a lawsuit claiming that nitrous oxide canisters sold online through Amazon.com contributed to serious injuries and addiction. MORE ABOUT: NITROUS OXIDE LAWSUITThe ‘Can’t Feel My Feet’ Symptom Doctors See in Nitrous Oxide Nerve Injury (01/16/2026)Lawsuit Alleges Nitrous Oxide Use Led to Child’s Death at Dentist (01/05/2026)Judge Transfers Galaxy Gas Lawsuits Over Nitrous Oxide Canister Sales to Same Court (12/29/2025) Lawyers Call for Hair Relaxer Cancer Lawsuit To Be Set for Trial (Posted: yesterday) Ahead of a case management conference this week, hair relaxer cancer lawsuit lawyers have asked a federal judge to set a date for the first bellwether trial. MORE ABOUT: HAIR RELAXER LAWSUITPresentations on How Hair Relaxers Cause Cancer Will Be Heard by MDL Judge This Week (01/05/2026)Hair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep (12/10/2025)Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (11/13/2025) Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 (Posted: 2 days ago) As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (01/15/2026)Cook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)
Amazon Nitrous Oxide Lawsuit Alleges Platform Responsible for Whippet Injuries (Posted: today) A Georgia man has filed a lawsuit claiming that nitrous oxide canisters sold online through Amazon.com contributed to serious injuries and addiction. MORE ABOUT: NITROUS OXIDE LAWSUITThe ‘Can’t Feel My Feet’ Symptom Doctors See in Nitrous Oxide Nerve Injury (01/16/2026)Lawsuit Alleges Nitrous Oxide Use Led to Child’s Death at Dentist (01/05/2026)Judge Transfers Galaxy Gas Lawsuits Over Nitrous Oxide Canister Sales to Same Court (12/29/2025)
Lawyers Call for Hair Relaxer Cancer Lawsuit To Be Set for Trial (Posted: yesterday) Ahead of a case management conference this week, hair relaxer cancer lawsuit lawyers have asked a federal judge to set a date for the first bellwether trial. MORE ABOUT: HAIR RELAXER LAWSUITPresentations on How Hair Relaxers Cause Cancer Will Be Heard by MDL Judge This Week (01/05/2026)Hair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep (12/10/2025)Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (11/13/2025)
Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 (Posted: 2 days ago) As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (01/15/2026)Cook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)